Mablink Bioscience announces a €31 million Series A f

Mablink Bioscience announces a €31 million Series A funding round led by Sofinnova Partners and Mérieux Equity Partners

Related Keywords

Milan , Lombardia , Italy , Paris , France General , France , London , City Of , United Kingdom , Jean Guillaume Lafay , Fondation Fournier Majoie , Mablink Adcs , Graziano Seghezzi , Mablink Biosciences , Alpha Fra , Mablink Bioscience , Florian Denis , I Mablink Bioscience , Europe Venture Fund , Sofinnova Partners , Equity Partners , Francei October , Chief Executive Officer , Managing Partner , Pertinence Invest , Investment Director , Elaia Partners , Sham Innovation Sant , Turenne Capital , Simba Sant , Folate Receptor Alpha , Venture Capital , Venture Fund , Biologics , Antibodies , Therapeutic Antibodies , Recombinant , Antibody Drug Conjugates , Dc , Immunoconjugates , Biosimilar Antibodies , Biosuperior Antibodies , Antibody Fragments , Scfv , Lab , Nanobodies , Domain Antibodies , Manufacturing ,